Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

1.3K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.7K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

957
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
957
Respiratory System Abnormal Finding I: Inspection and Percussion01:30

Respiratory System Abnormal Finding I: Inspection and Percussion

867
Respiratory system abnormalities are a significant concern in healthcare due to their potential to indicate underlying severe conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. These abnormalities can often be detected through physical examination methods like inspection and percussion.
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
867

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo VPS16 missense variant causes infantile-onset dystonia with defective autophagic flux.

JCI insight·2026
Same author

Reply to: Mathematical Comments on Linking Neurofilament Light Chain Levels to Disease Severity in Hereditary Spastic Paraplegia Subtypes SPG11 and SPG15.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

CRISPR/Cas9 loss-of-function screen in a neuronal model of AP-4 deficiency identifies ATG9A trafficking modulators.

JCI insight·2026
Same author

Genotype-structure-phenotype correlations define divergent natural history in early-onset spastic paraplegia type 4.

Brain : a journal of neurology·2026
Same author

Movement Disorders in Developmental and Epileptic Encephalopathies.

Movement disorders clinical practice·2026
Same author

Movement Disorders in Aicardi-Goutières Syndrome and Response to Immunomodulation.

Annals of clinical and translational neurology·2026
Same journal

Body-Brain Integration: The Lower Brainstem in Sleep-Wake Regulation.

Annual review of neuroscience·2026
Same journal

Planning in the Brain: It's Not What You Think It Is.

Annual review of neuroscience·2026
Same journal

The Emerging Neurobiology of Psychedelics: Critical Periods, Metaplasticity, and Extracellular Matrix Remodeling.

Annual review of neuroscience·2026
Same journal

Rethinking Predictive Processing.

Annual review of neuroscience·2026
Same journal

Path Integration in Alzheimer's Disease: Orientation, Movement, and Theta Rhythmicity.

Annual review of neuroscience·2026
Same journal

The Cellular and Circuit Basis of Temperature Sensation in <i>Drosophila</i>.

Annual review of neuroscience·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

Eye Tracking Young Children with Autism
09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

46.6K

Abnormal mTOR Activation in Autism.

Kellen D Winden1, Darius Ebrahimi-Fakhari1, Mustafa Sahin1

  • 1F.M. Kirby Neurobiology Center, Translational Neuroscience Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA;

Annual Review of Neuroscience
|March 1, 2018
PubMed
Summary
This summary is machine-generated.

The mechanistic target of rapamycin (mTOR) pathway is linked to autism spectrum disorder (ASD). mTOR inhibitors are being studied for potential treatments to improve neurodevelopmental outcomes in ASD.

Keywords:
PTENautismfragile XmTORrapamycintuberous sclerosis

More Related Videos

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

25.9K
A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

17.7K

Related Experiment Videos

Last Updated: Feb 13, 2026

Eye Tracking Young Children with Autism
09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

46.6K
Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

25.9K
A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

17.7K

Area of Science:

  • Biochemistry
  • Neuroscience
  • Genetics

Background:

  • The mechanistic target of rapamycin (mTOR) pathway is a critical regulator of cell growth and metabolism.
  • Dysregulation of the mTOR pathway is implicated in various genetic syndromes associated with autism spectrum disorder (ASD).
  • mTOR signaling plays a vital role in neuronal development and function, processes crucial for neurodevelopment.

Purpose of the Study:

  • To explore the association between mTOR signaling and the development of autism spectrum disorder (ASD).
  • To investigate the potential of targeting the mTOR pathway for therapeutic interventions in ASD.
  • To review the current understanding of mTOR's role in neurodevelopmental processes relevant to ASD.

Main Methods:

  • Review of existing scientific literature on mTOR signaling and ASD.
  • Analysis of studies investigating mTOR pathway components in neurodevelopment.
  • Examination of preclinical and clinical data on mTOR inhibitors in relevant models.

Main Results:

  • Abnormalities in mTOR signaling are frequently observed in syndromes where ASD is prevalent.
  • Disruptions in mTOR-dependent neuronal processes are hypothesized to contribute to ASD pathogenesis.
  • mTOR inhibitors show promise in preclinical studies for modulating neurodevelopmental pathways.

Conclusions:

  • The mTOR pathway represents a significant link between cellular processes and ASD development.
  • The clinical availability of mTOR inhibitors offers a promising avenue for therapeutic exploration in ASD.
  • Further research is warranted to fully elucidate the mechanisms and optimize the use of mTOR inhibitors for neurodevelopmental outcomes.